The White House revealed its strategies to Vaccinate children against COVID-19 between the ages of 5 to 11 that is still pending approval from US Food and Drug Administration.
The Biden administration said that they have safeguarded sufficient vaccines to Vaccinate the 28 million children ages 5 to 11. If the vaccination gets authorized by FDA for that age group then that will help to supply more than 25,000 pediatric and primary care offices, rural health clinics, community health centers, as well as pharmacies to regulate the vaccine shot.
The government will also be initiating a partnership with the Children’s Hospital Association to work with about 100 children’s hospital systems across the nation to set up vaccinations sites in November.
The Biden administration will be helping in distributing the vaccine to Schools and community-based sites with the help of Federal Emergency Management Agency funding.
The Department of Health and Human Services will run a public education campaign to reach the guardians and parents with precisely and customarily responsive evidence about the vaccine and risk associated with COVID-19 for kids.
FDA and Vaccine advisers are going to meet in the next week to deliberate Pfizer’s appeal to approve its vaccine to children ages 5 to 11. If Pfizer’s vaccine gets approved then it will become the first vaccine against COVID-19 for younger children. Pfizer/Biotech vaccine is currently authorized for age 16 and older and has emergency approval for children ages 12 and 15.